Noom review
The intro runs three weeks, the medication four, and the recurring charge answers to twelve.
The verdict
Noom's own footnote sets an initial three-week subscription bundled with four weeks of medication from $79, then $199 a month against a twelve-week subscription thereafter. The tirzepatide program is built identically at $149 and $349. The recurring figure is not a cancel-anytime monthly rate.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $195/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Noom sells a behavior-change program with compounded GLP-1 prescribing attached. The medication and the subscription are separate products billed on different schedules.
Who writes the prescription, and what do they see?
A prescription follows an eligibility review, and the program is presented as coaching first with medication as one component. Who writes the prescription is not named on the pricing pages, and what a clinician reviews before approving a dose is not described.
The coaching program is the thing Noom is known for, and the GLP-1 offer is layered onto it. That layering is why the terms run on different clocks: the subscription and the medication were never one product.
What happens when the dose goes up?
Nothing published ties a dose to either figure, so what four weeks of medication contains at the start and at maintenance is not stated. A buyer stepping up inside a twelve-week subscription cannot tell from the pages whether the medication charge moves with them.
What the price includes
Three weeks of subscription plus four weeks of medication is $79 to begin, which covers neither a calendar month nor a matching pair of terms. After that the charge is $199 a month, but the commitment underneath it is twelve weeks. Tirzepatide follows at $149 and $349. A reader comparing $199 against another seller's monthly rate is comparing a twelve-week term against a one-month one.
What it claims, and what it cites
The GLP-1 lines are compounded rather than manufactured, and no compounding pharmacy is named. The FDA does not review a compounded preparation before it is dispensed.
Where it holds up, and where it does not
- Strength: The terms are disclosed in a footnote
- Strength: Coaching is built in rather than sold apart
- Strength: Both molecules are offered
- Limitation: Three different term lengths in one sentence
- Limitation: The recurring charge assumes twelve weeks
- Limitation: Intro subscription and medication run unequal terms
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Noom. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who reads the footnote before the headline.
- Wrong for
- A buyer who needs a cancel-anytime monthly rate.
How Noom compares
| Seller | Who it suits | Go |
|---|---|---|
| Insured buyers who want coaching and insurance handling alongside a prescription | See Calibrate Health → | |
| Buyers content to commit a quarter at a time in one payment | See Queen RX → | |
| Buyers who can pay a full term at once and want the lowest rung | See LaSara Medical Group → |
More GLP-1 telehealth sellers reviews: InjectcoIvim HealthIvologistJoi + BlokesJune HealthKERNX Health
Sponsored alternative
Bodybuilding Health+
Readers who want to start without committing a year of money
Check Bodybuilding Health+ availability →Frequently asked
- Is $199 a month cancel-anytime?
- Noom's footnote charges it against a twelve-week subscription, so the commitment underneath the monthly figure is a quarter.
- What does the intro price cover?
- A three-week subscription bundled with four weeks of medication, from $79 for semaglutide and $149 for tirzepatide.
- Why do the terms not line up?
- The subscription and the medication are separate products on separate schedules, and the footnote prices them in one sentence.
- Is Noom expensive compared with other GLP-1 telehealth sellers?
- Noom publishes a starting figure of $195/mo. Across the 225 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $399 with a median of $179, which puts Noom above the median. The other 18 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.